Old Web
English
Sign In
Acemap
>
authorDetail
>
Christopher J. Endres
Christopher J. Endres
Seattle Genetics
Medicine
Pharmacokinetics
Anesthesia
Lymphoma
Brentuximab vedotin
2
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Tucatinib Inhibits Renal Transporters OCT2 and MATE Without Impacting Renal Function in Healthy Subjects.
2020
The Journal of Clinical Pharmacology
Ariel R. Topletz-Erickson
Anthony Lee
JoAl Mayor
Evelyn Rustia
Layth I. Abdulrasool
Amanda L. Wise
Ben Dailey
Sharon DeChenne
Luke Walker
Stephen C. Alley
Christopher J. Endres
Show All
Source
Cite
Save
Citations (2)
Population Pharmacokinetic Modeling and Exposure‐Response Assessment for the Antibody‐Drug Conjugate Brentuximab Vedotin in Hodgkin Lymphoma in the Phase III ECHELON‐1 Study
2019
Clinical Pharmacology & Therapeutics
Ajit Suri
Diane R. Mould
Gregory Song
Graham P. Collins
Christopher J. Endres
Jesus Gomez-Navarro
Karthik Venkatakrishnan
Show All
Source
Cite
Save
Citations (8)
1